Federal Register / Vol. 87, No. 115 / Wednesday, June 15, 2022 / Notices 36137 

Act of 1995 (PRA) (44 U.S.C. 3501– 

3520) is not required for this guidance. 

The previously approved collections of 

information are subject to review by 

OMB under the PRA. The collection of 

information in 21 CFR part 211 has been 

approved under OMB control number 

0910–0139. 

III. Electronic Access 

Persons with access to the internet 

may obtain the draft guidance at https:// 

www.regulations.gov, https://

www.fda.gov/drugs/guidancecompliance-regulatory-information/ 

guidances-drugs, or https://

www.fda.gov/vaccines-blood-biologics/ 

guidance-compliance-regulatoryinformation-biologics/biologicsguidances, or https://www.fda.gov/ 

regulatory-information/search-fdaguidance-documents. 

Dated: June 8, 2022. 

Lauren K. Roth, 

Associate Commissioner for Policy. 

[FR Doc. 2022–12919 Filed 6–14–22; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Announcement of Intent To Establish 

the 2025 Dietary Guidelines Advisory 

Committee and Solicitation of 

Nominations for Membership 

AGENCY: U.S. Department of Health and 

Human Services (HHS), Office of the 

Assistant Secretary for Health; U.S. 

Department of Agriculture (USDA), 

Food, Nutrition, and Consumer 

Services. 

ACTION: Notice. 

SUMMARY: The Departments of Health 

and Human Services and Agriculture 

announce the intent to establish a 

Dietary Guidelines Advisory Committee 

and invite nominations for the 

Committee. 

DATES: Nominations must be submitted 

by 11:59 p.m. Eastern Time on July 15, 

2022. 

ADDRESSES: Nominations may be 

submitted by email to 

DietaryGuidelines@hhs.gov. 

Alternatively, nominations may be sent 

to: Dietary Guidelines Advisory 

Committee Nominations, Office of 

Disease Prevention and Health 

Promotion (ODPHP), Office of the 

Assistant Secretary for Health (OASH), 

HHS; 1101 Wootton Parkway, Suite 420; 

Rockville, MD 20852. 

FOR FURTHER INFORMATION CONTACT: 

Janet de Jesus, MS, RD, Nutrition 

Advisor, telephone 240–453–8266, 

Office of Disease Prevention and Health 

Promotion, U.S. Department of Health 

and Human Services, 

DietaryGuidelines@hhs.gov. 

SUPPLEMENTARY INFORMATION: 

Authority and Purpose: Section 301 of 

the National Nutrition Monitoring and 

Related Research Act of 1990 (7 U.S.C. 

5341) requires the Secretaries of HHS 

and USDA to publish the Dietary 

Guidelines for Americans (Dietary 

Guidelines) jointly at least every five 

years. The law instructs that this 

publication shall contain nutritional 

and dietary information and guidelines 

for the general public, shall be based on 

the preponderance of scientific and 

medical knowledge current at the time 

of publication, and shall be promoted by 

each federal agency in carrying out any 

federal food, nutrition, or health 

program. The current edition of the 

Dietary Guidelines (2020–2025) 

provides guidance on the entire life 

span, from birth to older adulthood, 

including pregnancy and lactation. The 

Dietary Guidelines for Americans, 2025– 

2030 will continue to provide foodbased dietary guidance across the entire 

lifespan to help meet nutrient needs, 

promote health, and reduce the risk of 

chronic disease. 

The 2025 Dietary Guidelines Advisory 

Committee (Committee) shall be formed 

and governed under the provisions of 

the Federal Advisory Committee Act 

(FACA), Public Law 92–463, as 

amended (5 U.S.C., App), which sets 

forth standards for the formation and 

use of advisory committees. The 

Committee is established to provide 

independent, evidence-based advice 

and recommendations to be considered 

by HHS and USDA in the Departments’ 

development of the Dietary Guidelines 

for Americans, 2025–2030. The 

Committee’s review and advice will 

focus on the scientific questions 

prioritized by HHS and USDA with the 

potential to inform nutrition guidance 

for Americans across the lifespan. 

Formation of the Committee is 

necessary to adequately review the 

science to inform the Dietary Guidelines 

and is in the public interest. 

The Committee is expected to begin 

meeting in early 2023; the Committee 

will meet approximately five times 

during its operation. Pursuant to the 

FACA, all Committee meetings will be 

open to the public. The Committee will 

be established to accomplish a single, 

time-limited task. The Committee will 

develop a scientific report of its 

recommendations that will be submitted 

to the Secretaries of HHS and USDA. 

Upon delivery of its report to the 

Secretaries or when the Committee’s 

charter expires two years after it is filed, 

the activities of the Committee will be 

terminated. 

Structure: The Committee will consist 

of 15 to 20 members, including the 

Chair and Vice-Chairperson. Factors to 

be considered in selecting individuals to 

serve on the Committee include 

educational background, professional 

experience, and demonstrated scientific 

expertise in the issues to be examined 

by the Committee, as well as statutory 

obligations under FACA and desire for 

a balanced and diverse membership. 

Expertise in human nutrition related 

to disease prevention and health 

promotion for the specific scientific 

topics identified by the Departments to 

be examined by the Committee will be 

sought. Expertise will also be sought 

related to health equity and the 

scientific approaches used to review the 

evidence (systematic reviews, food 

pattern modeling, and data analysis). 

Information on the scientific topics is 

available at www.dietaryguidelines.gov. 

Equal opportunity practices regarding 

membership appointments to the 

Committee will be aligned with HHS 

and USDA policies. To the extent 

possible, HHS and USDA will ensure 

the Committee membership is balanced 

in expertise, experience, education, and 

institutional affiliation and is reflective 

of the racial, ethnic, gender, and 

geographic diversity within the United 

States. 

Individuals will be appointed to serve 

as members of the Committee to 

evaluate the scientific evidence, not to 

represent the viewpoints of any specific 

group. Members of the Committee will 

be classified as Special Government 

Employees (SGE)s during their term of 

appointment and, as such, are subject to 

the ethical standards of conduct for 

federal employees. Upon entering the 

position and annually throughout the 

approximate 2-year term of 

appointment, members of the 

Committee will be required to complete 

and submit a report of their financial 

holdings. 

Nominations and Appointments for 

Memberships: Nominees, including selfnominees, will be considered for 

appointment as members of the 

Committee. Only complete nomination 

packages submitted within the allotted 

time period will be considered. To be 

considered for an appointment, 

submission of the following information 

for each nominee is required: (1) a cover 

letter that clearly states the name and 

place of work of the nominee, the 

rationale for the nomination (i.e., which 

specific topics they have expertise in, 

highlighting relevant experience in 

health equity and the scientific 


jspears on DSK121TN23PROD with NOTICES1
36138 Federal Register / Vol. 87, No. 115 / Wednesday, June 15, 2022 / Notices 

approaches used by the Committee, if 

applicable), and a statement that the 

nominee would be willing to serve as a 

member of the Committee, if selected; 

(2) the name, address, telephone 

number, and email address for the 

individual being nominated and the 

nominator, if applicable; and (3) a copy 

of the nominee’s curriculum vitae, 

limited to no more than 15 pages. 

The curriculum vitae should include 

the following information: (a) education; 

(b) experience (current and former); (c) 

affiliations (food, nutrition, public 

health, and/or other relevant 

associations, including positions held); 

(d) current memberships (expert panels, 

committees, or other relevant groups, 

including positions held); (e) peerreviewed publications (for past 10 

years); (f) oral presentations (for past 5 

years); (g) editorials, opinion pieces, and 

blogs (for past 5 years); (h) grants, 

contracts, or research funding (for past 

15 years); (i) name of any corporation, 

professional society, association, panel, 

company, firm, government agency 

(federal, state, and local), research 

organization, educational institution, 

committee, or other organization or 

institution (government, private, and 

not-for-profit; domestic and foreign) in 

which the nominee’s services have 

been, will be, or are expected to be 

provided, with or without 

compensation, including on a part-time 

or seasonal basis as an officer, medical 

staff, board member, owner, trustee, 

director, expert advisor, consultant, 

official spokesperson, member of 

speakers bureau, or expert witness (for 

past 10 years and upcoming); (j) other 

paid travel or honoraria received, not 

included above (for past 5 years). If the 

nominee does not have anything to 

report for the section(s), indicate 

‘‘none.’’ Web links to publications, 

presentations, and other materials 

available online are requested, when 

available. 

Where prohibited by federal law or 

regulations, nominations will not be 

accepted directly from USDA research 

and promotion boards. Self-nominations 

and nominations by members of 

research and promotion boards in their 

individual capacity will be considered. 

Federal employees should not be 

nominated for consideration for 

appointment to this Committee. 

Rachel L. Levine, 

ADM, Assistant Secretary for Health, U.S. 

Department of Health and Human Services. 

[FR Doc. 2022–12865 Filed 6–14–22; 8:45 am] 

BILLING CODE 4150–32–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Healthcare Delivery 

and Methodologies Integrated Review Group; 

Population and Public Health Approaches to 

HIV/AIDS Study Section. 

Date: July 14–15, 2022. 

Time: 8:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Jose H. Guerrier, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5222, 

MSC 7852, Bethesda, MD 20892, 301–435– 

1137, guerriej@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Fellowships: Chemistry, Biochemistry and 

Biophysics A. 

Date: July 21, 2022. 

Time: 10:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Shan Wang, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, (301) 496–4390, shan.wang@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Fellowships: Surgical Sciences, Biomedical 

Imaging and Bioengineering. 

Date: July 22, 2022. 

Time: 12:00 p.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Weihua Luo, MD, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5114, 

MSC 7854, Bethesda, MD 20892, 301–435– 

1170, luow@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: June 9, 2022. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–12832 Filed 6–14–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Amended 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the Board of Scientific 

Counselors, National Cancer Institute, 

July 11, 2022, 11:00 a.m. to July 12, 

2022, 3:30 p.m., National Cancer 

Institute Shady Grove, 9609 Medical 

Center Drive, Rockville, MD 20850 

which was published in the Federal 

Register on June 6, 2022, FR Doc 2022– 

12046, 87 FR 34280. 

This notice is being amended to 

change the meeting end time on July 12, 

2022, from 3:30 p.m. to 4:15 p.m. The 

meeting will now be held on July 11, 

2022, from 11:00 a.m. to 2:40 p.m. and 

July 12, 2022, from 11:00 a.m. to 4:15 

p.m. The meeting will be held as a 

virtual meeting and is partially closed to 

the public. 

Dated: June 9, 2022. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–12834 Filed 6–14–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Request for Information: Inviting 

Comments and Suggestions From 

Stakeholders on Pediatric Medical 

Devices Public-Private Partnership 

AGENCY: National Institutes of Health, 

HHS. 

ACTION: Request for Information. 

SUMMARY: The National Institute of 

Child Health and Human Development 

(NICHD), in collaboration with the 

National Institute of Biomedical Imaging 

and Bioengineering (NIBIB), seek 


jspears on DSK121TN23PROD with NOTICES1